Healthcare provider profile · identity verified

Timothy E Rowland, MD

Family Practice · HILLIARD, OH · NPI 1629197314

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	773	225
Lisinopril	Lisinopril	319	86
Amlodipine Besylate	Amlodipine Besylate	317	94
Levothyroxine Sodium	Levothyroxine Sodium	238	70
Metoprolol Succinate	Metoprolol Succinate	228	63
Hydrochlorothiazide	Hydrochlorothiazide	214	67
Losartan Potassium	Losartan Potassium	204	59
Pantoprazole Sodium	Pantoprazole Sodium	192	68
Rosuvastatin Calcium	Rosuvastatin Calcium	167	46
Prednisone	Prednisone	151	110
Gabapentin	Gabapentin	145	45
Trazodone Hcl	Trazodone Hcl	132	42
Metformin Hcl Er	Metformin Hcl	125	40
Tamsulosin Hcl	Tamsulosin Hcl	122	39
Simvastatin	Simvastatin	115	34
Omeprazole	Omeprazole	114	33
Eliquis	Apixaban	109	28
Sertraline Hcl	Sertraline Hcl	106	25
Atenolol	Atenolol	101	29
Duloxetine Hcl	Duloxetine Hcl	100	29
Finasteride	Finasteride	99	30
Meloxicam	Meloxicam	99	35
Valsartan	Valsartan	95	30
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	91	91
Alendronate Sodium	Alendronate Sodium	88	29
Metoprolol Tartrate	Metoprolol Tartrate	86	24
Carvedilol	Carvedilol	83	24
Escitalopram Oxalate	Escitalopram Oxalate	83	27
Furosemide	Furosemide	81	30
Montelukast Sodium	Montelukast Sodium	70	20
Celecoxib	Celecoxib	68	23
Ezetimibe	Ezetimibe	66	17
Enalapril Maleate	Enalapril Maleate	62	15
Hydralazine Hcl	Hydralazine Hcl	62	21
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	62	18
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	62	16
Clopidogrel	Clopidogrel Bisulfate	60	16
Fluoxetine Hcl	Fluoxetine Hcl	60	19
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	58	16
Potassium Chloride	Potassium Chloride	54	16
Synthroid	Levothyroxine Sodium	53	12
Alprazolam	Alprazolam	52	23
Albuterol Sulfate Hfa	Albuterol Sulfate	50	19
Bupropion Xl	Bupropion Hcl	50	14
Citalopram Hbr	Citalopram Hydrobromide	49	13
Allopurinol	Allopurinol	48	14
Metformin Hcl	Metformin Hcl	47	16
Pravastatin Sodium	Pravastatin Sodium	47	13
Ozempic	Semaglutide	46	12
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	44	14
Doxepin Hcl	Doxepin Hcl	43	14
Nifedipine Er	Nifedipine	43	18
Xarelto	Rivaroxaban	43	suppressed
Cephalexin	Cephalexin	42	33
Tramadol Hcl	Tramadol Hcl	42	18
Shingrix	Varicella-Zoster Ge/As01b/Pf	39	34
Triamcinolone Acetonide	Triamcinolone Acetonide	39	26
Azithromycin	Azithromycin	38	35
Pioglitazone Hcl	Pioglitazone Hcl	38	suppressed
Mirtazapine	Mirtazapine	37	suppressed
Lorazepam	Lorazepam	35	suppressed
Spironolactone	Spironolactone	35	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	34	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	33	suppressed
Famotidine	Famotidine	32	suppressed
Glimepiride	Glimepiride	32	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	32	32
Zolpidem Tartrate	Zolpidem Tartrate	32	15
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	30	28
Glipizide	Glipizide	29	suppressed
Diazepam	Diazepam	28	suppressed
Tizanidine Hcl	Tizanidine Hcl	28	15
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	27	23
Warfarin Sodium	Warfarin Sodium	27	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	26	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	25	suppressed
Ipratropium Bromide	Ipratropium Bromide	24	11
Irbesartan	Irbesartan	24	suppressed
Myrbetriq	Mirabegron	23	suppressed
Cefdinir	Cefdinir	22	20
Doxycycline Hyclate	Doxycycline Hyclate	22	22
Acyclovir	Acyclovir	21	suppressed
Amoxicillin	Amoxicillin	21	15
Ciprofloxacin Hcl	Ciprofloxacin Hcl	21	14
Donepezil Hcl	Donepezil Hcl	21	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	21	suppressed
Jardiance	Empagliflozin	21	suppressed
Pregabalin	Pregabalin	21	suppressed
Ondansetron Hcl	Ondansetron Hcl	20	11
Valacyclovir	Valacyclovir Hcl	20	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	19	suppressed
Buspirone Hcl	Buspirone Hcl	19	suppressed
Fluticasone Propionate	Fluticasone Propionate	19	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	19	suppressed
Torsemide	Torsemide	19	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	18	18
Amitriptyline Hcl	Amitriptyline Hcl	18	suppressed
Cholestyramine	Cholestyramine (With Sugar)	18	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	18	suppressed
Niacin Er	Niacin	18	suppressed
Oxycodone Hcl	Oxycodone Hcl	18	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	18	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	17	suppressed
Ibandronate Sodium	Ibandronate Sodium	17	suppressed
Naproxen	Naproxen	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	16	suppressed
Rizatriptan	Rizatriptan Benzoate	16	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	15	suppressed
Januvia	Sitagliptin Phosphate	15	suppressed
Nystatin	Nystatin	15	suppressed
Fluconazole	Fluconazole	14	suppressed
Labetalol Hcl	Labetalol Hcl	14	suppressed
Levofloxacin	Levofloxacin	14	13
Wegovy	Semaglutide	14	suppressed
Breo Ellipta	Fluticasone/Vilanterol	13	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	13	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Phenobarbital	Phenobarbital	12	suppressed
Ramipril	Ramipril	12	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	12	suppressed
Colestipol Hcl	Colestipol Hcl	11	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	suppressed
Sildenafil Citrate	Sildenafil Citrate	11	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed
Vascepa	Icosapent Ethyl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error